Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Newborn screening for citrin deficiency and carnitine uptake defect using second-tier molecular tests.

BMC medical genetics - 10 Feb 2013

Wang Li-Yun, Chen Nien-I, Chen Pin-Wen, Chiang Shu-Chuan, Hwu Wuh-Liang, Lee Ni-Chung, Chien Yin-Hsiu

Abstract excerpt

BACKGROUND: Tandem mass spectrometry (MS/MS) analysis is a powerful tool for newborn screening, and many rare inborn errors of metabolism are currently screened using MS/MS. However, the sensitivity of MS/MS screening for several inborn errors, including citrin deficiency (screened by citrulline level) and carnitine uptake defect (CUD, screened by free carnitine level), is not satisfactory. This study was...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Organic Cation Transport Proteins
Share to Carnitine

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Citrulline

Share to Mitochondrial Membrane Transport Proteins

Share to Molecular Diagnostic Techniques

Share to Neonatal Screening

Share to Organic Anion Transporters

Share to Solute Carrier Family 22 Member 5

Source

Open in PubMed Open full text

Identifiers

PMID: 23394329
DOI: 10.1186/1471-2350-14-24
PMCID: PMC3575349

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Newborn screening for citrin deficiency and carnitine uptake defect using second-tier molecular tests.PMID 23394329Read ↗

Improved diagnosis of citrin deficiency by newborn screening using a molecular second-tier test.Semantic proximity Read ↗

Incorporating Next-Generation Sequencing as a Second-Tier Test for Primary Carnitine Deficiency.Semantic proximity Read ↗

Newborn screening for primary carnitine deficiency using a second-tier genetic test.Semantic proximity Read ↗

Newborn Screening for Inborn Errors of Metabolism by Next-Generation Sequencing Combined with Tandem Mass SpectrometrySemantic proximity Read ↗

MassARRAY-based targeted detection of SLC22A5 mutations: A feasibility study for secondary screening of primary carnitine deficiency in newborns.Semantic proximity Read ↗

Incorporating second-tier genetic screening for multiple acyl-CoA dehydrogenase deficiency.Semantic proximity Read ↗

Diagnoses of newborns and mothers with carnitine uptake defects through newborn screening.Semantic proximity Read ↗

Tandem Mass Spectrometry Screening for Inborn Errors of Metabolism in Newborns and High-Risk Infants in Southern China: Disease Spectrum and Genetic Characteristics in a Chinese PopulationSemantic proximity Read ↗

Clinical features and genotyping of patients with primary carnitine deficiency identified by newborn screening.Semantic proximity Read ↗

Development of a quantitative real-time PCR-based newborn screening system for citrin deficiency using dried blood spots.Semantic proximity Read ↗

Clinical and genetic analysis of 26 Chinese patients with neonatal intrahepatic cholestasis due to citrin deficiency.Semantic proximity Read ↗

Improved sensitivity and specificity for citrin deficiency using selected amino acids and acylcarnitines in the newborn screening.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.